Literature DB >> 23428592

Brief critical review: Statistical assessment of biomarker performance.

Thomas Kampfrath1, Stanley S Levinson.   

Abstract

INTRODUCTION: Articles have suggested that C-statistics associated with receiver operator characteristic (ROC) curves are insufficiently sensitive compared to odds/risk ratios (OR/RR) defined by p-values. Some suggest reclassification techniques are more appropriate.
METHODS: We review the concepts of p-values, OR/RR, and ROC curves. We construct a ROC curve, demonstrate parametric and nonparametric curves, and analyze a comparison of ROC curves.
RESULTS: Using these illustrations, we show that the ROC curve is not simply a C-statistic but a continuum of sensitivity/specificity pairs over decision levels. We demonstrate that p-values provide little useful information about discrimination and that OR/RR is a limited expression of a sensitivity/specificity plot. We illustrate that low prevalence produces low positive predictive values, reclassification techniques are subject to the same rules of prevalence as other analysis, and that modifying the analysis can decrease the p-value comparing C-statistics without altering the sensitivity/specificity plot.
CONCLUSIONS: ROC curves provide both visual and statistical information to support entry into large-scale trials, determining decision levels and the use of testing in the absence of such trials. If the sensitivity/specificity plot shows little improvement at appropriate decision point(s), statistically significant-improvement in other "novel" statistical indices should be suspect. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428592     DOI: 10.1016/j.cca.2013.02.006

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice?

Authors:  Johannes Mair; Allan S Jaffe
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

2.  RUNX3 site-specific hypermethylation predicts papillary thyroid cancer recurrence.

Authors:  Dan Wang; Wei Cui; Xiaoyan Wu; Yiping Qu; Na Wang; Bingyin Shi; Peng Hou
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

3.  Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.

Authors:  Zibo Li; Xinwu Guo; Lili Tang; Limin Peng; Ming Chen; Xipeng Luo; Shouman Wang; Zhi Xiao; Zhongping Deng; Lizhong Dai; Kun Xia; Jun Wang
Journal:  Tumour Biol       Date:  2016-07-23

4.  Secreted frizzled-related protein promotors are hypermethylated in cutaneous squamous carcinoma compared with normal epidermis.

Authors:  Junqin Liang; Xiaojing Kang; Yilinuer Halifu; Xuewen Zeng; Tianbo Jin; Mingxia Zhang; Dong Luo; Yuan Ding; Yunmin Zhou; Buwajier Yakeya; Dilinuer Abudu; Xiongming Pu
Journal:  BMC Cancer       Date:  2015-09-22       Impact factor: 4.430

Review 5.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.